Vom Hoffnungsträger zum Problemfall: Nestlé verkauft Vitaminmarken mit Milliardenverlust
Einst verfolgte Nestlé hochfliegende Pläne im Gesundheitsgeschäft. Der Konzernchef Philipp Navratil dampft sie ein.
Nestlé's former health-focused venture has been abandoned, as the company sold its mainstream vitamin brands for a billion-franc loss. Nestlé CEO Philipp Navratil closed the chapter on a painful episode of value destruction. The health-focused sector, once a promising hope for the company, has now vanished under Navratil's leadership.
The company's ambitious plans in the health industry were deemed too unrealistic, and the venture was ultimately sold for 800 million francs to American private-equity firm Yellow Wood Partners. The sale includes seven brands, primarily sold in the United States, such as Nature's Bounty. Despite the sale, Nestlé plans to continue its involvement in the health sector, focusing on products where it has a competitive edge, such as Solgar and Pure Encapsulations.
The company has also integrated its health activities more closely with its overall business. However, it is clear that Navratil is ending the dream of creating an independent health business within Nestlé, effectively burying the legacy of his predecessors.
Written by urgent.news from NZZ Wirtschaft's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
